Friday, 22 May 2009

Brevoxyl Acne Wash Kit


Generic Name: benzoyl peroxide topical (BEN zoyl per OX ide)

Brand Names: Acne Treatment, Acne-Clear, Benzac AC, Benzac W, Benzashave 10, Benzashave 5, BenzEFoam, Benziq, Benziq Wash, BPO Foaming Cloths, Brevoxyl, Brevoxyl Acne Wash Kit, Brevoxyl-4 Creamy Wash Complete Pack, Brevoxyl-8 Creamy Wash Complete Pack, Breze, Clearplex, Clearskin, Clinac BPO, Desquam-E, Desquam-X 10, Desquam-X 5, Desquam-X Wash, Fostex Bar 10%, Fostex Gel 10%, Fostex Wash 10%, Inova, Lavoclen-4, Lavoclen-8, Loroxide, NeoBenz Micro, Neutrogena Acne Mask, Neutrogena On Spot Acne Treatment, Oscion, Oscion Cleanser, Oxy 10 Balance, Oxy Balance, Oxy Daily Wash Chill Factor, Oxy-10, Pacnex, PanOxyl, Panoxyl 10, Panoxyl 5, Panoxyl Aqua Gel, PanOxyl Maximum Strength Foaming Acne Wash, Persa-Gel, Seba-Gel, SoluCLENZ Rx, Triaz, Triaz Cleanser, Zaclir


What is Brevoxyl Acne Wash Kit (benzoyl peroxide topical)?

Benzoyl peroxide has an antibacterial effect. It also has a mild drying effect, which allows excess oils and dirt to be easily washed away from the skin.


Benzoyl peroxide topical (for the skin) is used to treat acne.


Benzoyl peroxide topical may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Brevoxyl Acne Wash Kit (benzoyl peroxide topical)?


There are many brands and forms of benzoyl peroxide available and not all brands are listed on this leaflet.


Do not use benzoyl peroxide topical while you are also using tretinoin (Altinac, Avita, Renova, Retin-A, Tretin-X). Using these medications together could cause severe skin irritation.

Use this medication exactly as directed on the label, or as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended.


Avoid getting this medication in your mouth or eyes. If it does get into any of these areas, rinse with water. Do not use benzoyl peroxide topical on sunburned, windburned, dry, chapped, irritated, or broken skin. Also avoid using benzoyl peroxide topical on wounds or on areas of eczema. Wait until these conditions have healed before using this medication.

Avoid using skin products that can cause irritation, such as harsh soaps, shampoos, or skin cleansers, hair coloring or permanent chemicals, hair removers or waxes, or skin products with alcohol, spices, astringents, or lime. Do not use other medicated skin products unless your doctor has told you to.


Benzoyl peroxide may bleach hair or fabrics. Avoid allowing this medication to come into contact with your hair or clothing.


It may take several weeks before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve.


What should I discuss with my healthcare provider before using Brevoxyl Acne Wash Kit (benzoyl peroxide topical)?


Do not use benzoyl peroxide topical while you are also using tretinoin (Altinac, Avita, Renova, Retin-A, Tretin-X). Using these medications together could cause severe skin irritation. FDA pregnancy category C. It is not known whether benzoyl peroxide topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. It is not known whether benzoyl peroxide passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use Brevoxyl Acne Wash Kit (benzoyl peroxide topical)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.


Wash your hands before and after applying this medication. Shake the lotion well just before each use.

Clean and pat dry the skin to be treated. Apply benzoyl peroxide in a thin layer and rub in gently.


Do not cover the treated skin area unless your doctor has told you to.

Benzoyl peroxide topical is usually applied one to three times daily. Follow your doctor's instructions.


Benzoyl peroxide may bleach hair or fabrics. Avoid allowing this medication to come into contact with your hair or clothing.


It may take several weeks before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve.


Store at room temperature away from moisture and heat.

What happens if I miss a dose?


Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Brevoxyl Acne Wash Kit (benzoyl peroxide topical)?


Avoid getting this medication in your mouth or eyes. If it does get into any of these areas, rinse with water. Do not use benzoyl peroxide topical on sunburned, windburned, dry, chapped, irritated, or broken skin. Also avoid using benzoyl peroxide topical on wounds or on areas of eczema. Wait until these conditions have healed before using this medication.

Avoid using skin products that can cause irritation, such as harsh soaps, shampoos, or skin cleansers, hair coloring or permanent chemicals, hair removers or waxes, or skin products with alcohol, spices, astringents, or lime. Do not use other medicated skin products unless your doctor has told you to.


Avoid using sunscreen containing PABA on the same skin treated with benzoyl peroxide, or skin discoloration may occur.


Brevoxyl Acne Wash Kit (benzoyl peroxide topical) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using benzoyl peroxide and call your doctor at once if you have severe stinging or burning of your skin.

Less serious side effects may include:



  • mild stinging or burning;




  • itching or tingly feeling;




  • skin dryness, peeling, or flaking; or




  • redness or other irritation.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Brevoxyl Acne Wash Kit (benzoyl peroxide topical)?


It is not likely that other drugs you take orally or inject will have an effect on topically applied benzoyl peroxide topical. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Brevoxyl Acne Wash Kit resources


  • Brevoxyl Acne Wash Kit Side Effects (in more detail)
  • Brevoxyl Acne Wash Kit Use in Pregnancy & Breastfeeding
  • Brevoxyl Acne Wash Kit Drug Interactions
  • Brevoxyl Acne Wash Kit Support Group
  • 0 Reviews for Brevoxyl Acne - Add your own review/rating


  • Acne Treatment Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • BenzEFoam Foam MedFacts Consumer Leaflet (Wolters Kluwer)

  • Benzac Topical Advanced Consumer (Micromedex) - Includes Dosage Information

  • Benzac AC Wash MedFacts Consumer Leaflet (Wolters Kluwer)

  • Benzefoam Prescribing Information (FDA)

  • Benzefoam Ultra Prescribing Information (FDA)

  • Brevoxyl Gel MedFacts Consumer Leaflet (Wolters Kluwer)

  • Brevoxyl Creamy Wash Prescribing Information (FDA)

  • Desquam-X Wash Prescribing Information (FDA)

  • Inova Pads MedFacts Consumer Leaflet (Wolters Kluwer)

  • NeoBenz Micro Wash Plus Pack Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Neobenz Micro SD Prescribing Information (FDA)

  • Neobenz Micro Wash Plus Pack Prescribing Information (FDA)

  • Oxy Balance Topical Advanced Consumer (Micromedex) - Includes Dosage Information

  • Pacnex LP Prescribing Information (FDA)

  • PanOxyl Bar MedFacts Consumer Leaflet (Wolters Kluwer)

  • Triaz Cloths MedFacts Consumer Leaflet (Wolters Kluwer)

  • Triazolam Monograph (AHFS DI)



Compare Brevoxyl Acne Wash Kit with other medications


  • Acne
  • Perioral Dermatitis


Where can I get more information?


  • Your pharmacist can provide more information about benzoyl peroxide topical.

See also: Brevoxyl Acne side effects (in more detail)


Thursday, 21 May 2009

Dermophenazol




Dermophenazol may be available in the countries listed below.


Ingredient matches for Dermophenazol



Antazoline

Antazoline sulfate (a derivative of Antazoline) is reported as an ingredient of Dermophenazol in the following countries:


  • Poland

Naphazoline

Naphazoline nitrate (a derivative of Naphazoline) is reported as an ingredient of Dermophenazol in the following countries:


  • Poland

International Drug Name Search

Sunday, 17 May 2009

Docbromaze




Docbromaze may be available in the countries listed below.


Ingredient matches for Docbromaze



Bromazepam

Bromazepam is reported as an ingredient of Docbromaze in the following countries:


  • Belgium

International Drug Name Search

Sublimex




Sublimex may be available in the countries listed below.


Ingredient matches for Sublimex



Alprazolam

Alprazolam is reported as an ingredient of Sublimex in the following countries:


  • Guatemala

International Drug Name Search

Saturday, 16 May 2009

ranibizumab ophthalmic


Generic Name: ranibizumab (ophthalmic) (ra NIB i ZUE mab)

Brand Names: Lucentis


What is ranibizumab?

Ranibizumab is made from a human antibody fragment. It works by keeping new blood vessels from forming under the retina (a sensory membrane that lines the inside of the eye). In people with a certain type of eye disease, new blood vessels grow under the retina where they leak blood and fluid. This is known as the "wet form" of macular degeneration.


Ranibizumab is used to treat the wet form of age-related macular degeneration.


Ranibizumab may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about ranibizumab?


Do not receive this medication if you are allergic to ranibizumab, or if you have an infection in or around your eye. Before you receive this medication, tell your doctor if you have glaucoma.

Ranibizumab is given as an injection into your eye. Your doctor will use a medicine to numb your eye before giving you the injection. You will receive this injection in your doctor's office or other clinic setting.


Ranibizumab is usually given once a month. After you have received the first 4 injections, your doctor may change your injection schedule to once every 3 months. Follow your doctor's instructions.


Call your doctor at once if you have any of these serious side effects: vision changes, eye pain or redness, discharge or bleeding from your eye, increased eye sensitivity to light, swelling around the eye, or seeing flashes of light.

Call your doctor for instructions if you miss an appointment to receive your ranibizumab injection.


What should I discuss with my health care provider before receiving ranibizumab?


Do not receive this medication if you are allergic to ranibizumab, or if you have an infection in or around your eye.

Before you receive this medication, tell your doctor if you have glaucoma, or a history of blood clots or stroke.


FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether ranibizumab passes into breast milk or if it could harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby.

How is ranibizumab used?


Ranibizumab is given as an injection into your eye. Your doctor will use a medicine to numb your eye before giving you the injection. You will receive this injection in your doctor's office or other clinic setting.


Ranibizumab is usually given once a month. After you have received the first 4 injections, your doctor may change your injection schedule to once every 3 months. Follow your doctor's instructions.


For at least 30 minutes after your injection, your eyes will be checked periodically to make sure the injection has not caused any side effects.


To be sure this medication is helping your condition and not causing harmful effects, your eyes will also need to be checked on a regular basis. Do not miss any scheduled visits to your doctor.


What happens if I miss a dose?


Call your doctor for instructions if you miss an appointment to receive your ranibizumab injection.


What happens if I overdose?


Seek emergency medical attention if you think you have received too much of this medicine. Symptoms of a ranizumab overdose may include eye pain or vision changes.

What should I avoid while receiving ranibizumab?


There are no restrictions on food, beverages, or activity while receiving ranibizumab unless your doctor has told you otherwise.


Ranibizumab side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have any of these serious side effects:

  • vision changes;




  • eye pain, redness, or irritation;




  • discharge or bleeding from the eye;




  • increased eye sensitivity to light;




  • swelling around your eye;




  • seeing "stars" or flashes of light, especially in your peripheral (side) vision;




  • pain or burning when you urinate.




  • sudden numbness or weakness, especially on one side of the body; or




  • sudden headache, confusion, problems with vision, speech, or balance.



Other less serious side effects are more likely to occur, such as:



  • itchy or watery eyes;




  • dry eyes;




  • blurred vision;




  • runny or stuffy nose, cough, sore throat; or




  • joint or muscle pain.



Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.


Ranibizumab Dosing Information


Usual Adult Dose for Macular Degeneration:

Dose: 0.5 mg (0.05 mL) administered by intravitreal injection once a month (approximately every 28 days).

Usual Adult Dose for Macular Edema:

Dose: 0.5 mg (0.05 mL) administered by intravitreal injection once a month (approximately every 28 days).


What other drugs will affect ranibizumab?


There may be other drugs that can affect ranibizumab. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.



More ranibizumab resources


  • Ranibizumab Side Effects (in more detail)
  • Ranibizumab Use in Pregnancy & Breastfeeding
  • Ranibizumab Drug Interactions
  • Ranibizumab Support Group
  • 1 Review for Ranibizumab - Add your own review/rating


  • Lucentis Prescribing Information (FDA)

  • Lucentis Monograph (AHFS DI)

  • Lucentis Advanced Consumer (Micromedex) - Includes Dosage Information

  • Lucentis MedFacts Consumer Leaflet (Wolters Kluwer)

  • Lucentis Consumer Overview



Compare ranibizumab with other medications


  • Diabetic Retinopathy
  • Macular Degeneration
  • Macular Edema


Where can I get more information?


  • Your pharmacist has information about ranibizumab written for health professionals that you may read.

See also: ranibizumab side effects (in more detail)


Thursday, 14 May 2009

Opirasol




Opirasol may be available in the countries listed below.


Ingredient matches for Opirasol



Omeprazole

Omeprazole is reported as an ingredient of Opirasol in the following countries:


  • Vietnam

International Drug Name Search

Loratadina




Loratadina may be available in the countries listed below.


Ingredient matches for Loratadina



Loratadine

Loratadine is reported as an ingredient of Loratadina in the following countries:


  • Chile

  • Colombia

  • Ecuador

  • Venezuela

International Drug Name Search

Wednesday, 13 May 2009

Diertine




Diertine may be available in the countries listed below.


Ingredient matches for Diertine



Dihydroergocristine

Dihydroergocristine mesilate (a derivative of Dihydroergocristine) is reported as an ingredient of Diertine in the following countries:


  • Spain

International Drug Name Search

Tuesday, 12 May 2009

Calfate




Calfate may be available in the countries listed below.


Ingredient matches for Calfate



Sucralfate

Sucralfate is reported as an ingredient of Calfate in the following countries:


  • Portugal

International Drug Name Search

Sunday, 10 May 2009

Nalgestan




Nalgestan may be available in the countries listed below.


Ingredient matches for Nalgestan



Chlorphenamine

Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Nalgestan in the following countries:


  • Indonesia

Phenylpropanolamine

Phenylpropanolamine hydrochloride (a derivative of Phenylpropanolamine) is reported as an ingredient of Nalgestan in the following countries:


  • Indonesia

International Drug Name Search

Adrilan




Adrilan may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Adrilan



Epinephrine

Epinephrine bitartrate (a derivative of Epinephrine) is reported as an ingredient of Adrilan in the following countries:


  • Portugal

International Drug Name Search

Tuesday, 5 May 2009

rabies vaccine, human diploid cell


Generic Name: rabies vaccine, human diploid cell (RAY beez vax EEN, HUE man DYE ploid sel)

Brand Names: Imovax Rabies


What is rabies vaccine?

Rabies is a serious disease caused by a virus. Rabies is mainly a disease of animals. Humans get rabies when they are bitten by an infected animal. There may be no symptoms at first, but weeks or even years after a bite from an infected animal, rabies can cause pain, fatigue, headaches, irritability, fever, seizures, hallucinations, and paralysis. Rabies can be fatal.


You are more likely to be exposed to the rabies virus if you are a veterinarian, animal handler, rabies laboratory worker, or may otherwise come into contact with animals that could possibly carry the virus (including cats, dogs, foxes, skunks, raccoons, bobcats, coyotes, and bats). Travel to certain countries may also increase your risk of exposure to rabies.


Rabies human diploid cell vaccine is used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.


What is the most important information I should know about rabies vaccine?


Keep track of any and all side effects you have after receiving this vaccine. When you receive another vaccine in the future, you will need to tell the doctor if the first shot caused any side effects. Getting rabies disease is much more dangerous to your health than receiving this vaccine. However, like any medicine, this vaccine can cause side effects. The risk of serious side effects is extremely low.


You can still receive a rabies vaccine if you have a cold or other minor illness. If you have a more severe illness with a fever, wait until you recover before receiving this vaccine. However, if you have been bitten by an infected animal or otherwise exposed to the rabies virus, you should receive the rabies vaccine regardless of having another illness.


What should I discuss with my healthcare provider before receiving rabies vaccine?


Do not receive this vaccine if you have ever had an allergic reaction to a rabies vaccine.

If you have any of these other conditions, you may need a dose adjustment or special tests to safely receive this vaccine:



  • any type of infection or severe illness;




  • human immunodeficiency virus (HIV) infection;




  • a weak immune system caused by disease or by taking certain medicines or receiving cancer treatments; or




  • if you are taking medicine to treat or prevent malaria.



You can still receive a rabies vaccine if you have a cold or other minor illness. If you have a more severe illness with a fever, wait until you recover before receiving this vaccine. However, if you have been bitten by an infected animal or otherwise exposed to the rabies virus, you should receive the rabies vaccine regardless of having another illness.


FDA pregnancy category C. It is not known whether this vaccine is harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether rabies vaccine passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How is rabies vaccine given?


Rabies human diploid cell vaccine is given as an injection into a muscle. You will receive this injection in your doctor's office or other clinic setting. A doctor, nurse, or other healthcare provider will give you this injection.


For preventing rabies if you are at risk of exposure, you will need to receive a total of 3 injections. The second injection is usually given 7 days after the first, followed by a third injection 2 or 3 weeks later.


Depending on your risk of exposure to rabies, you may need to receive the rabies vaccine series every 2 years. If you work around live rabies virus, such as in a laboratory or a vaccine production area, you may need to receive a booster rabies vaccine every 6 months.


For treating rabies after you have been bitten or exposed, you will need to receive a total of 6 injections. The injections are usually given on Days 0, 3, 7, 14, 30, and 90. At the beginning of your treatment you may also receive a second injection with a rabies anti-serum or immune globulin (im-YOON GLOB-yoo-lin). This medicine is sometimes injected into or near the bite wound or injury where the rabies virus is likely to have entered your body.


Follow your doctor's instructions for your injection schedule.

What happens if I miss a dose?


Contact your doctor if you miss an appointment to receive your rabies vaccine.


What happens if I overdose?


An overdose of rabies vaccine is unlikely to occur.


What should I avoid before or after getting rabies vaccine?


There are no restrictions on food, beverages, or activity before or after receiving rabies vaccine.


Rabies vaccine side effects


Keep track of any and all side effects you have after receiving this vaccine. When you receive another vaccine in the future, you will need to tell the doctor if the first shot caused any side effects. Getting rabies disease is much more dangerous to your health than receiving this vaccine. However, like any medicine, this vaccine can cause side effects. The risk of serious side effects is extremely low.


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have any of these serious side effects:

  • fever, chills, weakness, body aches, flu symptoms;




  • joint pain; or




  • vomiting.



Less serious side effects are more likely to occur, such as:



  • pain, swelling, itching, or redness where the shot was given;




  • headache;




  • dizziness;




  • muscle pain; or




  • nausea, stomach pain.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report vaccine side effects to the US Department of Health and Human Services at 1-800-822-7967.


Rabies vaccine, human diploid cell Dosing Information


Usual Adult Dose for Rabies Prophylaxis:

Preexposure Prophylaxis:
1 mL IM for a total of 3 doses on days 0, 7, and 21 or 28.

Postexposure prophylaxis:
Not previously vaccinated:
1 mL IM for a total of 5 doses on days 0, 3, 7, 14, and 28. ( ACIP Provisional Recommendations, 2009,: 1 mL/dose for 4 doses, on days 0, 3, 7, 14 with immunocompromised patients to receive a fifth dose on day 28). Rabies immune globulin should also be administered on day 0 at 20 units/kg (half of this is infiltrated at bite site if possible, and the remainder is administered IM).

Previously vaccinated:
1 mL IM for a total of 2 doses on days 0 and 3. Do not administer rabies immune globulin.

Booster:
1 mL IM every 2 years or as indicated by antibody titers. People with continuing high risk of exposure such as certain veterinarians, should have their serum tested for rabies antibodies every 2 years; others working with live rabies in laboratories or vaccine production facilities and who are at risk of inapparent exposure should be tested every 6 months.

Usual Pediatric Dose for Rabies Prophylaxis:

Preexposure Prophylaxis:
1 mL IM for a total of 3 doses on days 0, 7, and 21 or 28.

Postexposure prophylaxis:
Not previously vaccinated:
1 mL IM for a total of 5 doses on days 0, 3, 7, 14, and 28. ( ACIP Provisional Recommendations, 2009,: 1 mL/dose for 4 doses, on days 0, 3, 7, 14 with immunocompromised patients to receive a fifth dose on day 28). Rabies immune globulin should also be administered on day 0 at 20 units/kg (half of this is infiltrated at bite site if possible, and the remainder is administered IM).

Previously vaccinated:
1 mL IM for a total of 2 doses on days 0 and 3. Do not administer rabies immune globulin.

Booster:
1 mL IM every 2 years or as indicated by antibody titers. People with continuing high risk of exposure such as certain veterinarians, should have their serum tested for rabies antibodies every 2 years; others working with live rabies in laboratories or vaccine production facilities and who are at risk of inapparent exposure should be tested every 6 months.


What other drugs will affect rabies vaccine?


Before receiving this vaccine, tell your doctor if you are using any of the following drugs:



  • chemotherapy or radiation cancer treatments;




  • cyclosporine (Neoral, Sandimmune, Gengraf);




  • sirolimus (Rapamune), tacrolimus (Prograf);




  • basiliximab (Simulect), efalizumab (Raptiva), muromonab-CD3 (Orthoclone);




  • mycophenolate mofetil (CellCept);




  • azathioprine (Imuran), leflunomide (Arava), etanercept (Enbrel);




  • a steroid medicine such as betamethasone (Celestone), cortisone (Cortone), dexamethasone (Decadron, Dexone), hydrocortisone (Cortef, Hydrocortone), methylprednisolone (Medrol), prednisolone (Prelone, Pediapred), prednisone (Orasone, Deltasone, others), or triamcinolone (Aristocort); or




  • an inhaled or nasal steroid such as beclomethasone (Qvar, Beclovent, Beconase, Vanceril, Vancenase), budesonide (Pulmicort, Rhinocort), flunisolide (Aerobid, Nasalide, Nasarel), fluticasone (Flovent, Flonase), mometasone (Nasonex), or triamcinolone (Azmacort, Nasacort).



If you are using any of these drugs, you may not be able to receive rabies vaccine, or you may need dosage adjustments or special tests during treatment.


There may be other drugs not listed that can affect rabies vaccine. Tell your doctor about all the prescription and over-the-counter medications you use, and other vaccines you receive. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.



More rabies vaccine, human diploid cell resources


  • Rabies vaccine, human diploid cell Side Effects (in more detail)
  • Rabies vaccine, human diploid cell Use in Pregnancy & Breastfeeding
  • Rabies vaccine, human diploid cell Drug Interactions
  • Rabies vaccine, human diploid cell Support Group
  • 0 Reviews for Rabies vaccine, human diploid cell - Add your own review/rating


  • Imovax Rabies Advanced Consumer (Micromedex) - Includes Dosage Information

  • Rabies Vaccine Monograph (AHFS DI)



Compare rabies vaccine, human diploid cell with other medications


  • Rabies Prophylaxis


Where can I get more information?


  • Your doctor or pharmacist may have additional information about rabies vaccine. You may also find additional information from your local health department or the Centers for Disease Control and Prevention.

See also: rabies vaccine, human diploid cell side effects (in more detail)


Kajos




Kajos may be available in the countries listed below.


Ingredient matches for Kajos



Potassium Citrate

Potassium Citrate is reported as an ingredient of Kajos in the following countries:


  • Norway

  • Sweden

International Drug Name Search

Friday, 1 May 2009

Ryzolt Extended-Release Tablets


Pronunciation: TRAM-a-dol
Generic Name: Tramadol
Brand Name: Examples include Ultram ER and Ryzolt


Ryzolt Extended-Release Tablets are used for:

Treating moderate to moderately severe chronic pain in certain patients.


Ryzolt Extended-Release Tablets are an analgesic. It works in certain areas of the brain and nervous system to decrease pain.


Do NOT use Ryzolt Extended-Release Tablets if:


  • you are allergic to any ingredient in Ryzolt Extended-Release Tablets

  • you have had a severe allergic reaction (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue) to codeine or another opioid (eg, morphine)

  • you have severe or persistent diarrhea due to taking an antibiotic

  • you have suicidal thoughts or actions or a history of alcohol or other substance abuse or addiction

  • you are intoxicated with alcohol, opioids or narcotics (eg, codeine, morphine), or sedatives or sleeping medicines (eg, temazepam, zolpidem)

  • you have severe liver or kidney problems

  • you are taking carbamazepine, nefazodone, sodium oxybate (GHB), a thioxanthene (eg, thiothixene), or another product that contains tramadol

Contact your doctor or health care provider right away if any of these apply to you.



Before using Ryzolt Extended-Release Tablets:


Some medical conditions may interact with Ryzolt Extended-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription (especially depression medicines) or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have liver, kidney, or thyroid problems; a blockage in the bladder; diabetes; heart problems (eg, cor pulmonale); high blood pressure; pancreas problems; prostate problems; or metabolism problems

  • if you have or recently have had any head injury, brain injury or tumor, increased pressure in the brain, or infection of the brain or nervous system

  • if you have a history of recent stomach or bowel surgery, or any other stomach or bowel problems (eg, pain, inflammation, ulcers)

  • if you have a history of lung or breathing problems (eg, asthma, chronic obstructive pulmonary disease [COPD]) or seizures (eg, epilepsy)

  • if you drink alcohol; you are going through withdrawal from alcohol or other substances; or if you have a history of alcohol or other substance abuse or addiction, mood or mental problems (eg, depression), or suicidal thoughts or actions

Some MEDICINES MAY INTERACT with Ryzolt Extended-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Alpha-2 receptor blockers (eg, yohimbine), azole antifungals (eg, ketoconazole), linezolid, lithium, macrolide antibiotics (eg, erythromycin), monoamine oxidase inhibitors (MAOIs) (eg, phenelzine, selegiline), nefazodone, quinidine, selective serotonin reuptake inhibitors (SSRIs) (eg, fluoxetine, paroxetine), serotonin-norepinephrine reuptake inhibitors (SNRIs) (eg, duloxetine), St. John's wort, tricyclic antidepressants (eg, amitriptyline), or "triptans" (eg, sumatriptan) because serotonin syndrome may occur

  • Anorexiants (eg, phentermine), butyrophenones (eg, haloperidol), cyclobenzaprine, furazolidone, loxapine, certain medicines for mental or mood disorders (eg, olanzapine), molindone, opioid pain medicines (eg, codeine , hydrocodone), phenothiazines (eg, promethazine), sleeping medicines (eg, zolpidem); sodium oxybate (GHB), thioxanthenes (eg, thiothixene), or tiagabine because the risk of side effects, including excessive drowsiness, trouble breathing, liver problems, or seizures, may be increased

  • Carbamazepine because it may decrease Ryzolt Extended-Release Tablets's effectiveness; the risk of seizures may also be increased

  • Other products containing tramadol because they may increase the risk of Ryzolt Extended-Release Tablets's side effects

  • Rifampin because it may decrease Ryzolt Extended-Release Tablets's effectiveness

  • Anticoagulants (eg, warfarin) or digoxin because the risk of their side effects may be increased by Ryzolt Extended-Release Tablets

This may not be a complete list of all interactions that may occur. Ask your health care provider if Ryzolt Extended-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Ryzolt Extended-Release Tablets:


Use Ryzolt Extended-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Ryzolt Extended-Release Tablets by mouth with or without food. Try to take it the same way (either with food or without food) each time you take your dose. Check with your doctor or pharmacist if you have questions about taking Ryzolt Extended-Release Tablets with food.

  • Swallow Ryzolt Extended-Release Tablets whole. Do not break, crush, or chew before swallowing.

  • If you miss a dose of Ryzolt Extended-Release Tablets and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Ryzolt Extended-Release Tablets.



Important safety information:


  • Ryzolt Extended-Release Tablets may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Ryzolt Extended-Release Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol while you are taking Ryzolt Extended-Release Tablets.

  • Check with your doctor before you use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers, narcotic pain medicines) while you are using Ryzolt Extended-Release Tablets; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Ryzolt Extended-Release Tablets may cause dizziness; alcohol, hot weather, exercise, or fever may increase this effect. To prevent it, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of this effect.

  • Do NOT take more than the recommended dose or take for longer than prescribed without checking with your doctor.

  • Tell your doctor or dentist that you take Ryzolt Extended-Release Tablets before you receive any medical or dental care, emergency care, or surgery.

  • Ryzolt Extended-Release Tablets may increase your risk of seizures. Your risk may be greater if you also have certain medical conditions, use certain medicines, or if you use a lot of alcohol. Talk to your doctor to see if you may have a greater risk of seizures while taking Ryzolt Extended-Release Tablets.

  • Serotonin syndrome is a possibly fatal syndrome that can be caused by Ryzolt Extended-Release Tablets. Your risk may be greater if you take Ryzolt Extended-Release Tablets with certain other medicines (eg, "triptans," MAOIs, antidepressants). Symptoms may include agitation; confusion; hallucinations; coma; fever; fast or irregular heartbeat; tremor; excessive sweating; and nausea, vomiting, or diarrhea. Contact your doctor at once if you have any of these symptoms.

  • Use Ryzolt Extended-Release Tablets with caution in the ELDERLY; they may be more sensitive to its effects, especially constipation, weakness or tiredness, severe light-headedness, and indigestion.

  • Ryzolt Extended-Release Tablets should not be used in CHILDREN younger than 16 years; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Ryzolt Extended-Release Tablets has been shown to cause harm to the fetus. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of taking Ryzolt Extended-Release Tablets while you are pregnant. Ryzolt Extended-Release Tablets are found in breast milk. Do not breast-feed while taking Ryzolt Extended-Release Tablets.

When used for long periods of time or at high doses, Ryzolt Extended-Release Tablets may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Ryzolt Extended-Release Tablets stops working well. Do not take more than prescribed.


Some people who use Ryzolt Extended-Release Tablets for a long time without a break may develop a physical need to continue taking it. This is known as physical DEPENDENCE.


If you suddenly stop taking Ryzolt Extended-Release Tablets, you may experience WITHDRAWAL symptoms, including anxiety; diarrhea; fever, runny nose, or sneezing; goose bumps and abnormal skin sensations; nausea; vomiting; pain; rigid muscles; rapid heartbeat; seeing, hearing or feeling things that are not there; shivering or tremors; sweating; and trouble sleeping. Do not suddenly stop taking Ryzolt Extended-Release Tablets without talking with your doctor. If you need to stop Ryzolt Extended-Release Tablets, your doctor will lower your dose over time.



Possible side effects of Ryzolt Extended-Release Tablets:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; diarrhea; dizziness; drowsiness; dry mouth; headache; increased sweating; indigestion; mild itching; nausea; trouble sleeping; vomiting; weakness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); agitation; chest pain; confusion; difficult or painful urination; disorientation; excessive sweating; fainting; fast or irregular heartbeat; fever; hallucinations; loss of coordination; mood or mental changes (eg, depression); red, blistered, swollen, or peeling skin; seizures; severe dizziness or light-headedness; severe nausea, vomiting, or diarrhea; severe or persistent headache; slow or shallow breathing; suicidal thoughts or behaviors; tremor; vision problems.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Ryzolt side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include bluish skin; cold, clammy skin; difficult, shallow, or slow breathing; drowsiness leading to unresponsiveness or coma; excessive sweating; limp muscles; pinpoint pupils; seizures; slow or irregular heartbeat.


Proper storage of Ryzolt Extended-Release Tablets:

Store Ryzolt Extended-Release Tablets at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Ryzolt Extended-Release Tablets out of the reach of children and away from pets.


General information:


  • If you have any questions about Ryzolt Extended-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.

  • Ryzolt Extended-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Ryzolt Extended-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Ryzolt resources


  • Ryzolt Side Effects (in more detail)
  • Ryzolt Use in Pregnancy & Breastfeeding
  • Drug Images
  • Ryzolt Drug Interactions
  • Ryzolt Support Group
  • 6 Reviews for Ryzolt - Add your own review/rating


Compare Ryzolt with other medications


  • Back Pain
  • Pain